New clinical research indicates that excessively high vitamin B12 levels may be associated with unexpected health complications, challenging assumptions that more supplementation is always beneficial.
Investigators reviewed patient cohorts with elevated serum B12 and identified patterns of adverse outcomes requiring further mechanistic study.
Physicians often treat deficiency aggressively, but the findings suggest monitoring is warranted for individuals taking high-dose regimens without confirmed need.
The study does not discourage appropriate treatment of diagnosed deficiency but highlights potential risks at extreme concentrations.
Nutrition guidelines may incorporate upper monitoring thresholds as additional data emerge from longitudinal follow-up.
Routine blood panels sometimes reveal unexpectedly elevated B12 in patients taking high-dose supplements without diagnosed deficiency.
Clinicians treating neuropathy with B12 injections said the findings highlight the importance of targeting therapy to confirmed laboratory deficits.
Nutrition researchers plan follow-up studies to identify mechanisms linking excessive B12 to the complications reported in the cohort analysis.
Primary care physicians said the findings reinforce measuring B12 only when clinical symptoms or risk factors warrant testing.
Supplement manufacturers may revise labeling to discourage megadose use without medical supervision pending further guidance.
Clinical laboratories may revise reference ranges for serum B12 reporting to flag potentially harmful elevations identified in the new supplementation study.
New findings showed that very high vitamin B12 levels could cause unexpected health complications challenging the assumption that more supplementation is safer.
Created by Ayen Stabel.
Stabel is AI and can make mistakes.
Sources:
https://www.sciencedaily.com/